Silibinin inhibits VEGF secretion and age-related macular degeneration in a hypoxia-dependent manner through the PI-3 kinase/Akt/mTOR pathway.

BACKGROUND AND PURPOSE: Hypoxia-mediated neovascularization plays an important role in age-related macular degeneration (AMD). There are few animal models or effective treatments for AMD. Here, we investigated the effects of the flavonoid silibinin on hypoxia-induced angiogenesis in a rat AMD model. EXPERIMENTAL APPROACH: Retinal pigmented epithelial (RPE) cells were subjected to hypoxia in vitro and the effects of silibinin on activation of key hypoxia-induced pathways were examined by elucidating the hypoxia-inducible factor-1 alpha (HIF-1α) protein level by Western blot. A rat model of AMD was developed by intravitreal injection of VEGF in Brown Norway rats, with or without concomitant exposure of animals to hypoxia. Animals were treated with oral silibinin starting at day 7 post-VEGF injection and AMD changes were followed by fluorescein angiography on days 14 and 28 post-injection. KEY RESULTS: Silibinin pretreatment of RPE cells increased proline hydroxylase-2 expression, inhibited HIF-1α subunit accumulation, and inhibited VEGF secretion. Silibinin-induced HIF-1α and VEGF down-regulation required suppression of hypoxia-induced phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin (mTOR) pathway. In the rat model of AMD, silibinin administration prevented VEGF- and VEGF plus hypoxia-induced retinal oedema and neovascularization. CONCLUSION AND IMPLICATIONS: The effects of silibinin, both in vitro and in vivo, support its potential as a therapeutic for the prevention of neovascular AMD.

Determination of organochlorine pesticides and their metabolites in soil samples using headspace solid-phase microextraction.

An analytical procedure was developed using headspace solid-phase microextraction (HS-SPME) for the determination of organochlorine pesticides (OCPs) and their metabolites in sandy soil samples. The developed procedures involving fiber selection, temperature effect, absorption time, soil matrix and the addition of solvents of different polarity were optimized. Also, the results were compared to those achieved using Soxhlet extraction standard method. The 100-microm polydimethylsiloxane (PDMS) and 65-microm PDMS-divinylbenzene showed good extraction efficiency for 18 organochlorine pesticides. An increase in the extraction efficiency of organochlorine pesticides and the metabolites was observed when the temperature increased, and an optimum temperature of 70 degrees C for extracting OCPs was obtained. The application of other hydrophilic solvents had different effects on the extraction of organochlorine pesticides and the metabolites. Higher responses of OCPs were obtained when 5 ml of water was added to the soil. Good linearity of OCPs between 0.2 and 4 ng/g soil was observed. The relative standard deviation was found to be lower than 25%. Also the limits of detection were between 0.06 and 0.65 ng/g, which were lower than those obtained using Soxhlet extraction. Moreover, the optimized HS-SPME procedure was applied to the analysis of OCPs in certified reference material (CRM) 804-050 soil and compared with Soxhlet extraction procedure. Results obtained in this study were in good agreement with those obtained using Soxhlet extraction. The mean values obtained using HS-SPME technique were in the range of 16.5 to 1459.6 mg/kg, which corresponds to the recoveries of 68% to 127% of the certified values of CRM soil.

Steroid-sensitive anemia in a boy on dialysis--an association with Kimura disease.

The cause of hypereosinophilia (EO) in hemodialysis (HD) patients is multifactorial and is felt to be a benign laboratory abnormality related to dialysis or uremia. Kimura disease (KD) is an angiolymphoid proliferative disorder of unknown etiology. Many cases are associated with nephrotic syndrome in children; however, it has seldom been reported in children on dialysis. We report here a 13-year-old boy who developed persistent EO and subsequent anemia after maintenance HD; he later developed KD. The atypical clinical manifestation of KD and its relationship to HD and erythropoietin hyposensitive anemia in this patient are discussed.

Substrate specificity of human glycinamide ribonucleotide transformylase.

The nucleotide substrate specificity of human glycinamide ribonucleotide transformylase, a chemotherapeutic target, has been examined. The enzyme accepts the sarcosyl analog of glycinamide ribonucleotide, carbocyclic glycinamide ribonucleotide, and two phosphonate derivatives of carbocyclic glycinamide ribonucleotide with V/K values, relative to that obtained for beta-glycinamide ribonucleotide, of 1, 27, 1.4, and 2.9%, respectively. Several other analogs of carbocyclic glycinamide ribonucleotide, namely a truncated phosphonate and 2',3'-dideoxy- and 2',3'-dideoxy-2',3'-didehydro-carbocyclic glycinamide ribonucleotide, were inhibitors of the enzyme, competitive against glycinamide ribonucleotide, with Ki values approximately 100 times higher than the Km for -glycinamide ribonucleotide. Although the results of the present study parallel those obtained previously with the avian enzyme (V. D. Antle, D. Liu, B. R. McKellar, C. A. Caperelli, M. Hua, and R. Vince (1996) J. Biol. Chem. 271, 6045-6049), quantitative differences between the two enzyme species have been uncovered.